FR3268M - New drug, in particular for the treatment of neurodepressive states and anxiety psychoses. - Google Patents

New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.

Info

Publication number
FR3268M
FR3268M FR956176D FR956176D FR3268M FR 3268 M FR3268 M FR 3268M FR 956176 D FR956176 D FR 956176D FR 956176 D FR956176 D FR 956176D FR 3268 M FR3268 M FR 3268M
Authority
FR
France
Prior art keywords
neurodepressive
psychoses
anxiety
states
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR956176D
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority claimed from FR956176A external-priority patent/FR1385619A/en
Application granted granted Critical
Publication of FR3268M publication Critical patent/FR3268M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR956176D 1963-12-05 1963-12-05 New drug, in particular for the treatment of neurodepressive states and anxiety psychoses. Expired FR3268M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR956176A FR1385619A (en) 1963-12-05 1963-12-05 New process for the preparation of intermediate compounds of the colchicine series and products obtained in this process

Publications (1)

Publication Number Publication Date
FR3268M true FR3268M (en) 1965-04-26

Family

ID=8818192

Family Applications (1)

Application Number Title Priority Date Filing Date
FR956176D Expired FR3268M (en) 1963-12-05 1963-12-05 New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.

Country Status (1)

Country Link
FR (1) FR3268M (en)

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3126M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3315M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2885M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3062M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3268M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR3665M (en) New drug, especially for the treatment of neuro-depressive states and anxiety psychoses.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1376735A (en) Double heating furnace, in particular for the treatment of hydrocarbons
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3641M (en) New drug in particular for the treatment of states of adynamia.